RFL
$1.91
Rafael Holdings
($.05)
(2.55%)
RFL
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Jan 30
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when RFL reports earnings?
Beat
Meet
Miss

Where is RFL's stock price going from here?
Up
Flat
Down
Stock chart of RFL
Analysts
Summary of analysts' recommendations for RFL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.